Loading...
Loading...
SRDX| Name | Value |
|---|---|
| Revenues | 28.1M |
| Cost of Revenue | 7.8M |
| Gross Profit | 20.3M |
| Operating Expense | 24.3M |
| Operating I/L | -4.0M |
| Other Income/Expense | -0.7M |
| Interest Income | 0.3M |
| Pretax | -4.7M |
| Income Tax Expense | 0.5M |
| Net Income/Loss | -5.2M |
Surmodics, Inc. provides surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. The company operates in two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment offers surface modification coating technologies to enhance medical device performance and drug-delivery coating technologies for site-specific drug delivery. The IVD segment designs and manufactures component products for diagnostic immunoassay and molecular test applications, including protein stabilization reagents, substrates, surface coatings, and antigens.
